Pneumothorax spontané et emphysème pulmonaire chez les consommateurs de cannabis

INTRODUCTION: If pulmonary complications of tobacco smoking are well documented, those associated with cannabis use are less known. OBJECTIVES: Systematic literature review of data on pneumothorax and lung emphysema in cannabis users. DOCUMENTARY SOURCES: Medline, on the period 1980-2018 with the following keywords cannabis or marijuana and pneumothorax or emphysema, limits "title/abstract". Among 97 articles, 42 abstracts have given use to a dual reading to select 20 studies. RESULTS: Eighteen case reports (8 with SP) showed bullae in the upper lobes in combined cannabis and tobacco smokers (CS) and in the 2 cannabis only smokers (COS). The risk of SP was increased in CS, but not in COS. In patients less than 35-years old presenting with SP, the incidence of bullae on thoracic computed tomography (CT) was higher in CS than in tobacco only smokers (TOS). CT in patients with SP showed no significant difference as regards of the prevalence, location and type of emphysema between CS and TOS. Proportion of low lung density areas was higher in CS than in non-smokers (NS), but was similar in TOS and NS. CONCLUSION: These results suggest a cumulative toxic effect of tobacco and cannabis on the risk of SP and lung emphysema

A primary care database study of asthma among patients with and without opioid use disorders

Substance misuse is associated with poor asthma outcome and death. People with opioid use disorder (OUD) may be at particular risk, however, there have been no case-control studies of asthma care and outcomes in this patient group. A primary care database study of patients with asthma aged 16–65 years was conducted using a matched case-control methodology. The dataset comprised 275,151 adults with asthma, of whom 459 had a clinical code indicating a lifetime history of OUD. Cases with a history of OUD were matched to controls 1:3 by age, gender, smoking status and deprivation index decile. Attendance at annual review (30%) and for immunisation (25%) was poor amongst the overall matched study population (N = 1832). Compared to matched controls, cases were less likely to have attended for asthma review during the previous 12 months (OR = 0.60, 95% CI 0.45–0.80) but had similar immunisation rates. Higher rates of ICS (OR = 1.50, 1.13–1.98) and oral prednisolone use (OR = 1.71, 1.25–2.40) were seen amongst those with a history of OUD and 7.2% had a concurrent diagnosis of COPD (OR = 1.86, 1.12–2.40). We found that people with asthma and a history of OUD have worse outcomes on several commonly measured metrics of asthma care. Further research is required to identify reasons for these findings, the most effective strategies to help this vulnerable group access basic asthma care, and to better understand long-term respiratory outcomes

Asthme et usage de cannabis, de cocaïne ou d’héroïne

International audienc

COVID-19 et modifications de l’usage de la cigarette électronique

International audienc

Cannabis et cancer bronchique

International audienceCannabis is the most commonly smoked illicit substance in the world. It can be smoked alone in plant form (marijuana) but it is mainly smoked mixed with tobacco. The combined smoking of cannabis and tobacco is a commonplace phenomenon in our society. However, its use is responsible for severe pulmonary consequences. The specific impact of smoking cannabis is difficult to assess precisely and to distinguish from the effect of tobacco. Marijuana smoke contains polycyclic aromatic hydrocarbons and carcinogens at higher concentration than tobacco smoke. Cellular, tissue, animal and human studies, and also epidemiological studies, show that marijuana smoke is a risk factor for lung cancer. Cannabis exposure doubles the risk of developing lung cancer. This should encourage clinicians to identify cannabis use and to offer patients support in quitting.Le cannabis est la substance psychoactive illicite la plus fumée dans le monde. S'il peut être consommé seul sous forme d'herbe (marijuana), il est pour l'essentiel fumé mélangé à du tabac. L'usage associé de tabac et de cannabis est un phénomène devenu banal dans notre société ; il est pourtant responsable de dommages respiratoires sévères. Le rôle propre du cannabis est difficile à distinguer de celui du tabac et à évaluer avec précision. La fumée de cannabis contient une concentration en hydrocarbures aromatiques polycycliques et en carcinogènes plus importante que celle du tabac. Des études cellulaires et tissulaires, chez l'animal et chez l'homme, ainsi que des études épidémiologiques, ont mis en évidence qu'elle était un facteur de risque de cancer bronchique. L'exposition à la fumée de marijuana multiplie, au moins par deux, le risque de développer un cancer bronchique. Cela doit encourager les praticiens à identifier la consommation de cannabis et à proposer aux consommateurs des prises en charge de sevrage

Influence of tobacco smoking on quality of life in patients with lung cancer

International audienceRésumé Le tabagisme est la cause principale de cancer bronchique. Ce type de cancer représentel’indicateur le plus spécifique des effets du tabac sur la santé. Quels que soient la variétéde cancer bronchique et le stade de la maladie, la poursuite du tabagisme a des conséquencesnégatives sur son évolution et son traitement. C’est pourquoi l’arrêt du tabac est une mesurede prise en charge indispensable chez les patients fumeurs atteints de cancers bronchiques. Ila été mis en évidence que les fumeurs ont une moins bonne qualité de vie que les non-fumeurs.Cette revue générale a pour objectif d’étudier la relation entre la consommation de tabac etla qualité de vie des patients atteints de cancers bronchiques. Parmi douze études retenues,six mettent clairement en évidence un effet délétère de la poursuite du tabagisme ou un effetbénéfique de l’arrêt du tabac sur la qualité de vie des patients ayant un cancer bronchique. Cebénéfice est d’autant plus grand que l’arrêt est plus précoce. Ces constats doivent conduire lescliniciens à prendre en charge leurs patients fumeurs ayant un cancer bronchique afin de lesaider dans leur démarche d’arrêt du tabac